Artificial Intelligence in Medicine and Healthcare: applications, availability and societal impact by GÓMEZ-GONZÁLEZ EMILIO
  
 
J R C  S C I E N C E  F O R  P O L I C Y  R E P O R T  
AI Watch  
Artificial Intelligence in Medicine and Healthcare: 
applications, availability and societal impact 
EUR 30197 EN 
 
 
This publication is a Science for Policy report by the Joint Research Centre (JRC), the European Commission’s science and knowledge 
service. It aims to provide evidence-based scientific support to the European policymaking process. The scientific output expressed does 
not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the 
Commission is responsible for the use that might be made of this publication. For information on the methodology and quality underlying 
the data used in this publication for which the source is neither Eurostat nor other Commission services, users should contact the 
referenced source. The designations employed and the presentation of material on the maps do not imply the expression of any opinion 
whatsoever on the part of the European Union concerning the legal status of any country, territory, city or area or of its authorities, or 
concerning the delimitation of its frontiers or boundaries. 
 
Contact information  
Email: EC-AI-WATCH@ec.europa.eu   
 
EU Science Hub 
https://ec.europa.eu/jrc 
 
JRC120214 
 
EUR 30197 EN 
 
 
PDF ISBN 978-92-76-18454-6 ISSN 1831-9424 doi:10.2760/047666 
 
 
Luxembourg: Publications Office of the European Union, 2020. 
 
© European Union, 2020 
 
 
 
 
 
 
The reuse policy of the European Commission is implemented by the Commission Decision 2011/833/EU of 12 December 2011 on the 
reuse of Commission documents (OJ L 330, 14.12.2011, p. 39). Except otherwise noted, the reuse of this document is authorised under the 
Creative Commons Attribution 4.0 International (CC BY 4.0) licence (https://creativecommons.org/licenses/by/4.0/). This means that reuse 
is allowed provided appropriate credit is given and any changes are indicated. For any use or reproduction of photos or other material that 
is not owned by the EU, permission must be sought directly from the copyright holders. 
 
All content © European Union 2020, except: Cover image © Sdecoret©AdobeStock, 2018 Peshkova©AdobeStock, 2018 
 
How to cite this report: Gómez-González, E. and Gómez, E., Artificial Intelligence in Medicine and Healthcare: applications, availability and 
societal impact, EUR 30197 EN, Publications Office of the European Union, Luxembourg, 2020, ISBN 978-92-76-18454-6, 
doi:10.2760/047666, JRC120214. 
 
 
 
 
 
 
 
i 
Contents 
Preface ..................................................................................................................................................................... 1 
Acknowledgements ................................................................................................................................................. 2 
Authors .................................................................................................................................................................... 3 
Executive Summary ................................................................................................................................................. 4 
List of acronyms and abbreviations ......................................................................................................................... 5 
Definitions................................................................................................................................................................ 7 
1 Introduction ..................................................................................................................................................... 11 
1.1 Methodology ........................................................................................................................................... 11 
1.2 Technology Availability Level (TAL) scale ................................................................................................ 12 
2 The context ...................................................................................................................................................... 13 
2.1 Artificial Intelligence defines a new and swiftly evolving scenario ......................................................... 13 
2.2 Economic impact ..................................................................................................................................... 13 
2.3 The coronavirus pandemic (COVID-19) disease ...................................................................................... 14 
3 The social impact of Artificial Intelligence in Medicine and Healthcare ......................................................... 15 
3.1 The main driver: the evolution of technology ........................................................................................ 15 
3.2 Potential benefits and pitfalls ................................................................................................................. 15 
3.3 Levels of availability of technologies ....................................................................................................... 16 
3.4 A proposal of classification of technologies according to their social impact ........................................ 16 
3.5 Ethical and social aspects to consider for classification.......................................................................... 17 
3.6 Urgent needs identified by the World Health Organization ................................................................... 20 
3.7 Changes for professionals ....................................................................................................................... 21 
3.8 Empowerment and the new role of patients .......................................................................................... 21 
3.9 ‘Extended Personalized Medicine’ .......................................................................................................... 22 
3.10 The risk of the division into several types of Medicine........................................................................... 23 
3.11 ‘Digital health scammers’ ........................................................................................................................ 24 
3.12 Affordability and inequality ..................................................................................................................... 24 
3.13 The fundamental role and risks of neuroscience .................................................................................... 24 
3.14 Gene editing, weaponization and bioterrorism ...................................................................................... 25 
4 A ‘Visual Overview’ of Artificial Intelligence in Medicine and Healthcare. ..................................................... 27 
5 A ‘Structured Overview’ of Artificial Intelligence in Medicine and Healthcare............................................... 29 
6 Policy challenges .............................................................................................................................................. 44 
6.1 Informed citizens ..................................................................................................................................... 44 
6.2 Key aspects to evaluate ........................................................................................................................... 44 
6.3 Towards a European leadership .............................................................................................................. 45 
7 An unexpected example: the coronavirus pandemic and its extraordinary social impact ............................. 47 
8 Conclusions ...................................................................................................................................................... 49 
 
 
ii 
9 References ....................................................................................................................................................... 50 
Appendix: Selected conferences in 2019 .............................................................................................................. 87
 
 
1 
Preface 
This research is framed in the context of the HUMAINT project (Human Behaviour and Machine 
Intelligence, web portal at https://ec.europa.eu/jrc/communities/en/community/humaint) of the 
Centre for Advanced Studies, Joint Research Center of the European Commission and linked to AI 
Watch, the European Commission knowledge service to monitor the development, uptake and impact 
of Artificial Intelligence (AI) for Europe, launched in December 2018.  
AI has become an area of strategic importance and a key driver of economic development. As part of 
its Digital Single Market Strategy, the Commission put forward in April 2018 a European strategy on AI 
in its Communication ‘Artificial Intelligence for Europe’ COM(2018)237 [1]. The aims of the European 
AI strategy announced in the communication are: 
— To boost the EU's technological and industrial capacity and AI uptake across the economy, both by 
the private and public sectors. 
— To prepare for socio-economic changes brought about by AI. 
— To ensure an appropriate ethical and legal framework. 
Subsequently, in December 2018, the European Commission and the Member States published a 
‘Coordinated Plan on Artificial Intelligence’ COM(2018)795  [2], on the development of AI in the EU.  
The Plan foresees the creation of EU AI Watch, the ‘Commission Knowledge Service to Monitor the 
Development, Uptake and Impact of Artificial Intelligence for Europe’. AI Watch is developed by the 
Joint Research Centre (JRC) in collaboration with the Directorate‑General for Communications 
Networks, Content and Technology (DG CONNECT).  
AI Watch aims to monitor industrial, technological and research capacity, policy initiatives in the 
Member States, uptake and technical developments of Artificial Intelligence and its impact in the 
economy and public services. It provides a number of analyses necessary to monitor and facilitate the 
implementation of the European Strategy for AI.  All results of this analysis are published on the AI 
Watch portal (https://ec.europa.eu/knowledge4policy/ai-watch_en). AI Watch has a European focus 
within the global landscape, and engages in its activities with Member States. From AI Watch in-depth 
analyses, we will be able to understand better European Union’s areas of strength and areas where 
investment is needed. AI Watch will provide an independent assessment of the impacts and benefits 
of AI on growth, jobs, education, and society.  
The Commission also established a High-Level Expert Group that published Guidelines on trustworthy 
AI in April 2019  [3], and in the ‘White Paper On Artificial Intelligence - A European approach to 
excellence and trust’ COM(2020)65 [4], the Commission acknowledges that as with any new 
technology, the use of AI brings both opportunities and risks. Citizens fear being left powerless in 
defending their rights and safety when facing the information asymmetries of algorithmic decision-
making, and companies are concerned by legal uncertainty. 
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Executive Summary 
This report reviews and classifies the current and near-future applications of Artificial Intelligence (AI) 
in Medicine and Healthcare according to their ethical and societal impact and the availability level of 
the various technological implementations. It provides conceptual foundations for well-informed 
policy-oriented work, research, and forward-looking activities that address the opportunities and 
challenges created in the field of AI in Medicine and Healthcare. This report is aimed for policy 
developers, but it also makes contributions that are of interest for researchers studying the impact and 
the future of AI on Healthcare, for scientific and technological stakeholders in this field and for the 
general public. 
This report is based on an analysis of the state of the art of research and technology, including 
software, personal monitoring devices, genetic tests and editing tools, personalized digital models, 
online platforms, augmented reality devices, and surgical and companion robotics. From this analysis, 
it is presented the concept of ‘extended personalized medicine’, and it is explored the public 
perception of medical AI systems, and how they show, simultaneously, extraordinary opportunities 
and drawbacks. In addition, this report addresses the transformation of the roles of doctors and 
patients in an age of ubiquitous information and identifies three main paradigms in AI-supported 
Medicine: ‘fake-based’, ‘patient-generated’, and ‘scientifically tailored’ views. 
This Report presents:  
— An updated overview of the many aspects related to the social impact of Artificial Intelligence and 
its applications in Medicine and Health. A new ‘Technology Availability Level (TAL) Scale’ is defined 
to evaluate and compare their current status.  
— Recent examples of the growing social concerns and debates in the general press, social media and 
other web-bases sources. 
— A ‘Visual Overview of AI and AI-mediated technologies in Medicine and Healthcare’, in which two 
figures show, respectively, a (newly proposed) classification according to their ethical and social 
impact, and the most relevant ethical and social aspects considered for such classification. Some 
key questions, controversies, significant, and conflicting issues are outlined for each aspect. 
— A ‘Structured Overview’, with a sorted list of technologies and their implementations, including 
perspectives, conflicting views and potential pitfalls, and a corresponding, extensive list of 
references. 
— A conclusive set of policy challenges, namely the need of informed citizens, key aspects (of AI and 
AI-mediated technologies in Medicine and Healthcare) to evaluate, and some recommendations 
towards a European leadership in this sector.  
— We finally relate our study with an update on the use of AI technologies to fight the SARS-CoV-2 
virus and COVID-19 pandemic disease.  
 
The main scientific result of this Report has been published in the following reference: 
Gómez-González Emilio, Gómez Emilia, Márquez-Rivas Javier, Guerrero-Claro Manuel, Fernández-
Lizaranzu Isabel, Relimpio-López María Isabel, Dorado Manuel E., Mayorga-Buiza María José, 
Izquierdo-Ayuso Guillermo, Capitán-Morales Luis. Artificial intelligence in medicine and healthcare: a 
review and classification of current and near-future applications and their ethical and social impact. 
arXiv 2020. http://arxiv.org/abs/2001.09778  [5]. 
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List of acronyms and abbreviations  
Acronyms and abbreviations employed in this Report and related references are listed in the following 
Table 1. It is important to note that some of them are also used -with the same or different meaning 
and expression- in other contexts of science and technology, even in areas related to Medicine and 
Health. 
Table 1. List of the main acronyms and abbreviations employed in this Report. 
AI Artificial Intelligence 
AR Augmented Reality 
BCI Brain Computer Interfaces 
CAD, CADx Computer Aided Diagnosis 
CADe Computer Aided Detection 
CDSS Clinical Decision Support System 
CNN Convolutional Neural Networks 
CT Computed Tomography 
DIY Do-It-Yourself 
DL Deep Learning 
DS Decision Support 
DTC Direct-to-Consumer (genetic) test 
EC European Commission 
ED Emergency Department 
EHR Electronic Health Record 
EU European Union 
FDA Food and Drug Administration (of the USA) 
GDPR General Data Protection Regulation (of the EU) 
HCI Human-Computer Interaction/Interface 
ICT Information and Communication Technologies 
ICU Intensive Care Unit 
IGS Image Guided Surgery 
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IOI Intra-Operative Imaging (during a surgical procedure) 
IO Intra-Operative (inside the OR, during the procedure) 
IoT Internet Of Things 
IT Information and Telecommunications 
IMDRF International Medical Device Regulators Forum 
JRC Joint Research Centre (of the European Commission) 
(L)AWS (Lethal) Autonomous Weapons System 
ML Machine Learning 
MR(I) Magnetic Resonance (Imaging) 
OR Operating Room 
PET Positron Emission Tomography 
R&D Research and Development 
R&D&I Research and Development and Innovation 
SaMD Software as a Medical Device 
SAR, SR Socially Assistive Robot, Social Robot 
SME Small and Medium Enterprise 
SW Software 
TAL Technology Availability Level 
TRL Technology Readiness Level 
UN United Nations 
UNESCO United Nations Educational, Scientific and Cultural Organization 
USA United States of America 
VR Virtual Reality 
WHO World Health Organization 
WIPO World International Patent Organization 
WMA World Medical Association 
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Definitions  
In the context of this Report, the terms listed in the following Table 2 are to be understood as declared 
in this section. Their definitions are quoted from the indicated references and links. 
Table 2. Some specific terms in this Report.   
Artificial Intelligence Big Data Declaration of Geneva Deep Learning 
Digital Health eHealth Global Health Ethics Health 
In-silico In-vitro In-vivo International 
Medical Device 
Regulators Forum 
Machine Learning Medicine Software as a Medical 
Device 
Social Impact (of a 
technology) 
Sustainable Goals The Global South The Goal of Health The West 
Universal Health 
Coverage 
   
 
Artificial Intelligence: Modern dictionary definitions focus on Artificial Intelligence (AI) being a sub-
field of computer science and how machines can imitate human intelligence (being human-like rather 
than becoming human) [6]. In a broad sense, it may be understood as the study of how to produce 
machines that have (some of the) qualities of the human mind, such as the ability to understand 
language, recognize pictures, solve problems, take decisions and learn [7]. Other authors consider AI 
‘broadly defined as the science and engineering of making intelligent machines, especially intelligent 
computer programs’ [8]. 
However, definitions of artificial intelligence begin to shift based upon the goals trying to be achieved 
with the AI system [6]. Generally, there may be considered three types of AI: systems aimed at 
genuinely simulating human reasoning (and behavior) tends to be called ‘strong AI’, systems that can 
produce results similar to humans (but may use very different methods) are ‘weak AI’ and ‘in-between’ 
systems are those informed or inspired by human reasoning. This tends to be where most of the more 
powerful work is happening today (in industry). The ‘in-between’ systems use human reasoning as a 
guide, but they are not driven by the goal to perfectly model or reproduce it [9].  
Most current applications of AI in Medicine and Health may be considered of the ‘in-between’ type, as 
‘only inspired’ by the human reasoning, but many others are certainly evolving to become ‘strong AI’ 
systems.   
UNESCO states that ‘Artificial intelligence can be a great opportunity to accelerate the achievement of 
sustainable development goals. But any technological revolution leads to new imbalances that we 
must anticipate’. 
From: https://en.unesco.org/artificial-intelligence 
Big Data: Digital data that, through its volume or complexity, surpasses human analytical abilities and 
traditional data processing methods. 
From: https://en.unesco.org/courier/2018-3/lexicon-artificial-intelligence and 
https://en.wikipedia.org/wiki/Big_data 
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Declaration of Geneva1: It is one of the World Medical Association’s (WMA) oldest policies. As stated 
by the WMA, ‘it was adopted by the Second General Assembly in Geneva in 1947. It builds on the 
principles of the Hippocratic Oath. It also remains one of the most consistent documents of the WMA. 
With only very few and careful revisions over many decades, it safeguards the ethical principles of the 
medical profession, relatively uninfluenced by zeitgeist and modernism’. 
From: https://www.wma.net/what-we-do/medical-ethics/declaration-of-geneva/ 
The WMA furthers states that ‘the Oath should not be read alone, but in parallel with the more specific 
and detailed policies of the WMA especially the International Code of Medical Ethics, which followed 
the Declaration of Geneva as early as 1948’. 
From: https://www.wma.net/policies-post/wma-international-code-of-medical-ethics/  
Deep Learning: As defined by UNESCO, it is ‘a technique, at the cutting edge of machine learning, that 
enables a machine to independently recognize complex concepts such as elements in images. This is 
done by scouring millions of images […] that have not been labelled by humans. The result of a 
combination of learning algorithms and formal neural networks and the use of mass data, deep 
learning has revolutionized artificial intelligence. It has countless applications, including search 
engines, medical diagnosis, autonomous cars, etc’. 
From: https://en.unesco.org/courier/2018-3/lexicon-artificial-intelligence 
Digital Health: As recognized by the World Health Organization, digital technologies ‘can offer limitless 
possibilities to improve health, from personal fitness to building stronger health systems for entire 
countries’. 
From: https://www.who.int/behealthy/digital-health  
eHealth: As defined by the World Health Organization, ‘it is the use of information and communication 
technologies (ICT) for health’. 
From: https://www.who.int/ehealth/en/ 
Global Health Ethics: The Global Health Ethics Unit from the World Health Organization ‘provides a 
focal point for the examination of ethical issues raised by activities throughout the Organization. The 
unit also supports Member States in addressing ethical issues that arise in their own countries. This 
includes a range of global bioethics topics; from public health surveillance to developments in 
genomics, and from research with human beings to fair access to health services’. 
From: https://www.who.int/ethics/en/ 
Health: As defined by the World Health Organization, ‘Health is a state of complete physical, mental 
and social well-being and not merely the absence of disease or infirmity’. 
The Universal Declaration of Human Rights states, in its 25th Article, that ‘Everyone has the right to a 
standard of living adequate for the health and well-being of himself and of his family, including food, 
clothing, housing and medical care […]’. 
From: https://www.un.org/en/universal-declaration-human-rights/index.html 
The World Health Organization Constitution was the first international instrument to enshrine the 
enjoyment of the highest attainable standard of health as a fundamental right of every human being 
(‘the right to health’). 
From: https://www.who.int/en/news-room/fact-sheets/detail/human-rights-and-health 
 
1 Not to be confused with the Convention of Geneva (1949) which defines the international law for humanitarian 
treatment in war. 
 
 
9 
In-silico: Medical, biological research performed on computer or via computer simulation, that is, ‘in 
chips’, as opposed to being conducted in living organisms (in-vivo) or in a laboratory environment 
outside living organisms (in-vitro).  
From: https://en.wikipedia.org/wiki/In_silico 
In-vitro: Medical, biological research performed outside living organisms, that is, ‘within the glass’, in 
a laboratory environment as opposed to being conducted in living organisms (in-vivo),  
From: https://en.wikipedia.org/wiki/In_vitro 
In-vivo: Medical, biological research performed in living organisms. 
From: https://en.wikipedia.org/wiki/In_vivo 
International Medical Device Regulators Forum: It is a group of medical device regulators from around 
the world that have voluntarily come together to harmonize the regulatory requirements for medical 
products that vary from country to country.  
From:https://www.fda.gov/medical-devices/cdrh-international-programs/international-medical-
device-regulators-forum-imdrf 
Their current members represent medical device regulatory authorities in many countries. The 
European member is the European Commission Directorate-General for Internal Market, Industry, 
Entrepreneurship and SMEs. The USA member is the Food and Drug Administration. The World Health 
Organization is an Official Observer. 
Machine Learning: It is defined as an artificial intelligence technique that can be used to design and 
train software algorithms to learn from and act on data. Software developers can use machine learning 
to create an algorithm that is ‘locked’ so that its function does not change, or ‘adaptive’ so its behavior 
can change over time based on new data [8]. 
As stated by UNESCO, it is an automatic learning program to solve problems from examples, enabling 
it to compare and classify data, and even recognize complex shapes. Before the advent of deep 
learning in 2010, this type of program (i.e. machine learning) needed to be overseen by humans. For 
example, each image had to be explicitly designated as containing certain elements so that the 
machine could perform the requested recognition operation. 
From: https://en.unesco.org/courier/2018-3/lexicon-artificial-intelligence 
Medicine: It is the science and practice of establishing the diagnosis, prognosis, treatment, and 
prevention of disease. Medicine encompasses a variety of healthcare practices evolved to maintain 
and restore health by the prevention and treatment of illness. 
From: https://en.wikipedia.org/wiki/Medicine 
Software as a Medical Device: The International Medical Device Regulators Forum (IMDRF) defines it 
as ‘software intended to be used for one or more medical purposes that performs these purposes 
without being part of a hardware medical device’. Use of Software as a Medical Device is continuing 
to increase.  It can be used across a broad range of technology platforms, including medical device 
platforms, commercial ‘off-the-shelf’ platforms, and virtual networks, to name a few. Such software 
was previously referred to by industry, international regulators, and health care providers as 
‘standalone software’, ‘medical device software’ and/or ‘health software’, and can sometimes be 
confused with other types of software. 
From: https://www.fda.gov/medical-devices/digital-health/software-medical-device-samd 
Social Impact (of a technology): The risks, uncertainties, ethical dilemmas and other issues (besides 
economical, scientific or technological impacts) that come together with technological innovations and 
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may affect the society at any level, from individuals to structured groups and states. The social impact 
of a technology may influence –and even determine– its acceptance, rejection or modification [10]. 
Sustainable Goals: United Nations define them as the blueprint to achieve a better and more 
sustainable future for all. They address the global challenges we face, including those related to 
poverty, inequality, climate, environmental degradation, prosperity, and peace and justice. Health is 
the Sustainable Goal number 3. The full list of the 17 sustainable goals of the United Nations is: 
https://www.un.org/sustainabledevelopment/sustainable-development-goals/ 
The Global South: It is an emerging term (used by the World Bank) to refer to countries located in Asia, 
Africa, Latin America and the Caribbean and considered to have low and middle income. The Global 
South is one half of the global North-South divide, and does not necessarily refer to geographical south. 
Most people in the Global South live within the Northern Hemisphere. 
From: https://en.wikipedia.org/wiki/Global_South 
The Goal of Health: This is the Sustainable Goal number 3 of the United Nations. It is needed to ensure 
healthy lives and promote well-being for all at all ages.  
From: https://www.un.org/sustainabledevelopment/health/ 
The West: It is an emerging term used in analogy to The Global South by the World Bank. It refers to 
countries located in Europe, North America and other regions considered to have high income. The 
West does not necessarily refer to geographical west.  
Universal Health Coverage: It is one of the Sustainable Development Goals agreed by Member States 
of the United Nations to try to achieve by 2030.  
UHC means that all individuals and communities receive the health services they need without 
suffering financial hardship. It includes the full spectrum of essential, quality health services, from 
health promotion to prevention, treatment, rehabilitation, and palliative care. 
From: https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc) 
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1 Introduction 
Artificial Intelligence (AI) is a new realm of science and technology. It already affects many human 
activities at all societal levels, from individuals to social groups, corporations and nations. AI is 
expanding rapidly, worldwide, in almost every industrial, economical and societal sector, from 
information technologies to commerce, manufacturing, space, remote sensing, security and defense, 
transport and vehicles and, since the beginning of the XXI century, it is effectively entering into 
Medicine and Healthcare. 
Recent advances in AI systems in Medicine and Healthcare present extraordinary opportunities in 
many areas of deep social interest together with significant questions and drawbacks, calling for a close 
consideration of their implementation and how they affect –and can even change– basic definitions in 
the medical context.  
The Objective of this Report is to provide a review of existing and near-future applications of AI in this 
particular sector. It also provides the first classification of such applications from the point of view of 
their potential benefits and pitfalls, and ethical and social impact, and presents a set of controversial 
issues that are not deeply discussed in the literature and should be further researched.   
This Report presents:  
— An updated overview of the many aspects related to the social impact of Artificial Intelligence 
and its applications in Medicine and Health. A new ‘Technology Availability Level (TAL) Scale’ 
is defined to evaluate and compare their current status.  
— Recent examples of the growing social concerns and debates in the general press, social media 
and other web-bases sources. An update on the use of AI technologies to fight the SARS-CoV-
2 virus and COVID-19 pandemic disease is also included.  
— A ‘Visual Overview’, in which two figures show, respectively, the proposed classification of AI 
and AI-mediated technologies in Medicine and Healthcare according to their ethical and social 
impact (Figure 1), and the most relevant ethical and social aspects considered for such 
classification (Figure 2). Some key questions, controversies, significant, and conflicting issues 
are outlined for each aspect. 
— A ‘Structured Overview’, with a sorted list of topics related to AI and AI-mediated applications 
in Medicine and Health. They include technologies and their implementations, perspectives, 
conflicting views and potential pitfalls, and their corresponding references, as detailed in Table 
3. The total number of references included is 605. 
This Report does not include:  
— Thorough compilations of references for each specific technical area.  
— Topics related to AI technologies that are common to other areas, such as analysis of the 
economic aspects and of their use for education or specialized training, productivity, 
efficiency, workflow or automation. 
 
1.1 Methodology 
This Report is based on systematic searches of references in standard scientific, academic, institutional, 
medical, corporate and technical online platforms. It also presents examples (of social impact and 
growing concerns and debates) from general press, social media and other web-bases sources. Most 
references are only from the last three years (i.e. from 2017 to 2019), to highlight only the most recent 
advances. However, some other works considered of relevance are also included. 
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Scientific references have been compiled using Mendeley Reference Manager®2 and Vancouver 
Citation Style Language (CSL). Press references mainly come from media included in the Top European 
Newspapers in English – TheBigProject [11]. 
Full (standard) citations correspond to the numbers in square brackets.  
All topics, concepts and technologies mentioned in this Report are supported by their specific 
references as shown in Table 3 within the ‘Structured Overview’ (section 5). The total number of 
references included is 605. 
 
1.2 Technology Availability Level (TAL) scale 
In order to analyze the different AI applications and their current status, in this Report it is proposed a 
novel scale named ‘Technology Availability Level’ (TAL) to give a qualitative description of the degree 
of availability of a technology. In a numerical scale in 10 steps (levels), it ranges from 0 (unknown 
status, not considered feasible) to 9 (available for the general public).  
The TAL scale is similar in format (and related) to the standard ‘Technology Readiness Level’ (TRL) scale 
commonly used to assess R&D&I figures, but it is based on published references (in scientific and 
academic literature, industrial or corporate reports, and in general media citing sources considered to 
be reliable according to standards).  
It is important to consider that ‘availability’ is not necessarily equivalent to ‘readiness levels’ due to 
such factors as disclosure according to industrial, proprietary and/or government strategies, and that 
the TAL scale does not evaluate either the fulfillment of regulatory processes.  
The values defined for the TAL scale are the following: 
TAL 0. Unknown status. Not considered feasible according to references. 
TAL 1. Unknown status. Considered feasible according to related, indirect references. 
TAL 2. General/basic idea publicly proposed. 
TAL 3. Calls for public funding of research and development (R&D) open. 
TAL 4. Results of academic/partial projects disclosed. 
TAL 5. Early design of product disclosed. 
TAL 6. Operational prototype/'first case' disclosed. 
TAL 7. Products disclosed but not available. 
TAL 8. Available products for restricted (e.g. professional) users. 
TAL 9. Available for the public. 
 
 
 
 
2 www.mendeley.com  
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2 The context  
2.1 Artificial Intelligence defines a new and swiftly evolving scenario 
The fast and powerful evolution of AI since the beginning of the XXI century results from –and is 
fostered by– a number of concurrent factors. The main one is the simultaneous availability of powerful 
and cost-effective computing (processing) tools, hardware (e.g. graphics processing units), software 
and applications –even in consumer-grade personal computers and mobile devices– and of large (Big) 
data sets, with many different types and formats of information, both in online and cloud platforms 
and generated in real time by user wearables and the Internet of Things (IoT).  
Key roles in the generalization of AI technologies are also played by the expansion of open source 
coding resources, online communities of users and developers sharing resources, expertise (know-
how) and experience, and the combination of computer processing with other technologies such as 
photonics (merging of applied optics and electronics), robotics, and human-machine interfaces. 
From a geostrategic point of view, leadership in AI is openly recognized by some countries (e.g. Russia, 
2017) as the key element for world supremacy in the coming decades. Some leading countries started 
to promote strong investment in AI since the middle (e.g. USA) and the end of the XX century (e.g. 
China). The European Union has reinforced its efforts and began coordination among Member States 
in AI relatively recently. Some European countries already have definite strategies for AI. Others are 
still in the process. 
 
2.2 Economic impact 
The economic impact of AI3 is expected to be extraordinarily high in the short, medium and long terms, 
in all sectors, worldwide, and by 2030, estimates indicate a total global impact of 14.23 trillion euros 
($15.7 trillion) [12]. The European Commission set about 2.6 billion euros for AI and robotics in the 
Horizon 2020 plan and 9.2 billion euros for the period 2012-2017 in related areas (including AI and 
high-performance computing) [13]. Although gross domestic products (GDPs) of Europe and USA are 
similar and slightly higher than that of China, the percentages of digital information and 
communications technology in 2017 was 1.66% for Europe versus 2.16% for China and 3.33% for the 
USA [14]. In patents related to AI systems, China, USA and Japan account for 78% of the registries 
(since 2014). AI patents are mainly filed by companies and of the top 20 applicants, 12 are from Japan, 
3 from USA and 2 from China. Of the academic applicants, 17 out of the top 20 are from China [15]. As 
a global estimate, it is considered that by 2030 the economic impact of AI will increase to 26.1% of the 
GDP in China and 14.5% in North America. In Northern Europe, it will be 9.9% and 11.9% in Southern 
Europe [12]. 
Recent estimates value the economic impact of AI in Medicine and Health in staggering figures. Health 
costs are around 10% or higher for gross domestic products of many EU countries (in 2016) [16]. The 
growth in health AI market is about 40% and, only in the USA, AI applications in Medicine can save 
$150 billion in annual health costs by 2026 [17]. Only one sector, the genetic testing market, will reach 
$22 billion in 2024. Currently, there are about 75,000 gene tests available, many of which are direct-
to-consumer tests [18]. 
 
 
3 The economic data from [12] to [17] are provided only as a rough, qualitative indication of the very high 
relevance of the sector under analysis, and of the relative position of Europe as compared to other main 
competitors worldwide. The study of the economic impact of AI in Medicine and Health Care is a complex 
task not included in this Report. 
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2.3 The coronavirus pandemic (COVID-19) disease 
In December 2019, by the closing of references for this Report (see 1.1), news emerged about the 
appearance of an unknown virus in the province of Hubei, in central, mainland China. It belongs to the 
family of coronaviruses (CoV), particularly to those related to severe acute respiratory syndrome 
(SARS). On 11 February 2020 it was named as ‘severe acute respiratory syndrome coronavirus 2’ (SARS-
CoV-2) and the associated disease as ‘coronavirus disease’ (COVID-19) [19].  
Transmission of the virus from human to human was acknowledged in January 2020 and, without any 
vaccine or treatment, it quickly spread worldwide. On March 11th the COVID-19 outbreak was declared 
as a pandemic by the WHO [20]. By the end of March 2020, the epicenter of cases moved from China 
to Europe, strongly affecting the European Union and expanding into other geographical areas. 
Potential economic and societal impact is expected to be extraordinarily high. Fighting the disease is 
an on-going, international priority in which AI-related technologies play an essential role. 
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3 The social impact of Artificial Intelligence in Medicine and Healthcare 
The advent of AI into Medicine and Health may be considered as an on-going, (partially) unnoticed 
revolution. It combines the potential of disruptive advances with extraordinary benefits in Medicine 
and Healthcare with many unknowns and very questionable, and clearly negative, issues. In addition, 
AI it has already opened the door to completely new paradigms in Medicine and Health.  
In this section 3, only some significant aspects of AI and AI-mediated technologies in Medicine and 
Healthcare are specifically mentioned. A summarized ‘Visual Overview’ is shown in Figure 1 and Figure 
2 in section 4, and a thorough, sorted list of every topic and their corresponding references are detailed 
in the ‘Structured Overview’ in section 5 (Table 3). The total number of references included is 605. 
 
3.1 The main driver: the evolution of technology 
As detailed in Table 3, AI and AI-mediated technologies in Medicine and Healthcare have experienced 
an extraordinary evolution, from computer programs to support the analysis of medical images to its 
integration in almost every clinical and organizational area.  
Radiology was at the forefront of this transformation, together with different branches of surgery using 
augmented reality devices and surgical robots. They were quickly followed by other image-related 
specialties (e.g. pathology and laboratory, dermatology, ophthalmology) and, more recently, by 
virtually all areas of Medicine and Healthcare, from general practitioners to rare diseases to emergency 
departments, epidemiology, and disease management.  
Systems for ‘computer-aided diagnosis’ have expanded to include online assistants (e.g. app, 
chatbots), both for very specific medical areas (e.g. oncology, predicting the response to treatments) 
and for the general public, intraoperative imaging devices have evolved into full ‘image guided 
surgery’, even with non-invasive modalities and combined with surgical robotics, while ‘clinical robots’ 
now include ‘social companions’ for hospitalized person, particularly children and the elderly.  
In addition, wearables and IoT devices allow for real-time monitoring of physiological information, 
even at home, and, integrated with medical and social-media data, can trigger clinically related 
automated interventions (from suicide prevention calls to police to medication delivery). 
From a technological perspective, some areas of particular relevance as related to AI applications in 
Medicine and Healthcare are photonics, robotics, and computers and data science.   
Concerned –even healthy– citizens can now order direct-to-consumer genetic tests among many 
thousands in the market. New tools for big data modeling, analysis, and visualization are also 
expanding, and provide substantial, transforming improvements in clinical pathways, from the 
generation of ‘digital twins’ of individual patients to self-management of treatments. There are even 
online, crowd shared platforms for such high-end applications as radiotherapy. Many management 
aspects related to health economy (e.g. increased efficiency, quality control, fraud reduction) and 
policy also benefit from the new AI mediated tools. They even offer new hopes of improvements in 
health for environments with reduced resources and in developing regions. 
However, as detailed in what follows, technical challenges and ethical concerns remain, and new 
important questions arise. 
 
3.2 Potential benefits and pitfalls 
For European citizens, many applications and devices based on advanced AI technologies are already 
integrated in daily life (e.g. social networks, online commerce and other services), with some 
questioning on issues related to privacy and data protection. Topics subject to discussion usually origin 
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in some available or ‘nearly coming’ technologies (e.g. autonomous vehicles), with an open debate on 
some ethical and social issues (human-in-the-loop, responsibility, effects on professionals and 
employment). However, in general (that is, not only in Europe) the social effects and the impact of AI 
systems on human beings are barely studied before the technology is available and begins to spread. 
Questions usually arise after the systems are deployed. 
A significant example of AI-related applications which have recently started an international public 
debate about the deep social and ethical aspects of the technology is that of (lethal) autonomous 
weapons systems (LAWS), popularly named as ‘(autonomous) killer robots’ (detailed in 3.5). 
With reference to the classification proposed in Figure 1, some of the applications of AI in Medicine 
and Healthcare show clear beneficial aspects for humans, such as personalized medicine and disruptive 
improvements in diagnosis, drug design, tailored treatment, evaluation and monitoring of diseases 
(precision medicine), prosthetics and companion robots to care for the disabled and the elderly, and 
the development of systems for prevention, early detection and outbreak assessment of pandemics 
and events of public health.  
Other applications of AI in Medicine and Healthcare may be considered questionable. Among them, 
their potential use for ‘social engineering’ and profiling, fully autonomous robotic physicians and 
surgeons, self-experimentation medicine, reading of brain signals and external control of neural 
processes, brain implants, human-animal embryos and the quest for artificial life and synthetic life 
forms.  
And some other applications of AI in Medicine and Healthcare may be considered as clearly negative, 
such as scamming and malicious use of health data, bioterrorism and evil biohacking (manipulation of 
the human genome and introduction of malicious changes in the genetic heritage). 
 
3.3 Levels of availability of technologies 
Based on published references, many of the aforementioned AI and AI-mediated technologies in 
Medicine and Healthcare are already starting to become available, at very different stages and degrees 
of implementation. Certainly, some of them are at their very beginning (and some may even not be 
operational at all) but, in general, they are no longer science fiction, but really on-going technologies. 
As described in the Methodology section, the availability of systems and devices is described using a 
(newly proposed in this Report) scale called TAL (‘Technology Availability Level’). The TAL gives a 
qualitative description of the degree of availability of a technology, in a numerical scale of 10 steps 
(levels), from 0 (unknown status, not considered feasible) to 9 (available for the general public). The 
TAL scale is similar in format (and related) to the standard ‘Technology Readiness Levels’ (TRL) but, as 
mentioned, it is based on published references (in scientific and academic literature, industrial or 
corporate reports, and in general media citing sources considered to be reliable according to 
standards). As mentioned, it is important to consider that ‘availability’ is not necessarily equivalent to 
‘readiness levels’ due to such factors as disclosure according to industrial, proprietary and/or 
government strategies, and that the TAL scale does not evaluate either the fulfillment of regulatory 
processes.  
 
3.4 A proposal of classification of technologies according to their social impact 
In this Report, it is presented a graded classification of AI and AI-mediated technologies according to 
their ethical and social impact according to their beneficial vs detrimental character as recognized in 
the reviewed literature (Table 3). The aspects employed to construct this classification are detailed in 
3.5 and summarized in Figure 2.  
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According to literature, there are no previous classification of AI systems and applications in Medicine 
and Healthcare taking into account their potential benefits and pitfalls from ethical and societal points 
of view. For each of the many applications of AI in Medicine and Healthcare, it is reported the 
technology, the specific implementations behind and their level of availability according to published 
references.  
Nevertheless, the proposed classification of AI and AI-mediated applications in Medicine and 
Healthcare shown in Figure 1 is not intended to define an ‘absolute’ scale of ‘goodness’ or ‘badness’, 
as many technologies (e.g. gene editing, neuroprostheses) are not necessarily ‘positive’ or ‘negative’, 
and others may certainly be difficult to categorize. The ethical and social features employed to 
construct this classification (Figure 2) are also a subject open to discussion. 
 
3.5 Ethical and social aspects to consider for classification 
The ethical and social aspects to be considered for the analysis of Artificial Intelligence and AI-mediated 
applications in Medicine and Healthcare in this Report are summarized in Figure 2.  They can be 
considered as divided into three partially overlapping sets (Groups G1, G2 and G3). 
The First Group (G1) includes topics currently under analysis, as raised by other areas of prior 
development of AI applications (e.g. social networks, online commerce, automation in factories, 
autonomous vehicles), such as:  
— Data privacy, integrity and anonymity, legal responsibility and accountability, and other 
general aspects of the relationship of humans with (at least partially autonomous) machines 
[see also Second Group G2]. 
— The effects on medical professionals and on their relationships to both patients and 
employers, quality control and monitoring of workers. These effects include the need for 
professional updates, training and qualification, and the effects on employment (lost jobs, new 
jobs, deep changes in some medical specialties, the risk that some of them may even 
disappear). 
— Security and reliability [see also Second Group G2]. 
— Metrics of performance, improved health outcomes and clinical pathways, reduction of 
medical errors, personalized medicine and psychosocial outcomes. It is important to note that 
current AI systems are good –even outperforming humans– at ‘narrow’, specific tasks (e.g. 
locating certain elements or patterns in images) while (still) failing in global, overview analysis. 
— The existence of a ‘human-in-the-loop’ with or without the ability to override the system, and 
the questions that arise if there is no time/possibility for human intervention in a critical –even 
life or death– situation. 
The Second Group (G2) includes topics –some of which may also be under analysis in other areas– of 
particular relevance for Medicine and Healthcare, such as:  
— Explainability and interpretability of the systems. These concepts refer to being able to explain 
the ‘reasoning process’ of AI systems to a human operator. It is currently required by 
legislation but the evolution of AI technology leads to systems too complex to be understood 
by a human. Since they may give better results than humans (at least, in certain tasks), should 
we accept the results given by AI systems without being able to understand how they (‘the 
machines’) came to them? 
— Trust and reliability. If ‘a machine’ performs better than a human, what to do when they give 
conflicting opinions?  
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— Data quality. The generation of suitable databases and repositories of medical data and 
information for learning and development of AI systems. 
— Data security. The social impact of malicious data alterations can be particularly severe since 
certain health issues (e.g. toxic consumption history, genetic disposition to diseases) may be 
manipulated to blackmail or discredit individuals and groups, for instance in processes related 
to employment and profiling.   
Moreover, AI applications in Medicine and Healthcare define a business environment in which 
economic figures roar to the order of millions, making them a desirable target for illicit, adversarial 
attacks. As in any other computer services, there are risks of hacking and data theft but, in addition, 
those of malicious manipulation of the algorithms and data used to train the systems. 
Alterations in how a system learns may produce changes in diagnosis and prescriptions, affecting billing 
and insurances, and even ‘small’ changes on images and data sets can alter such important outcomes 
as the benignancy or malignancy of lesions. Inserting or removing only a ‘critical’ element in an image 
(e.g. a malignant nodule, a crack in a bone) requires only a few pixels and it is much easier to make 
than already existing ‘fake’ photographs and videos. Such manipulations can be used in many malicious 
applications, from fraud to insurances to massive sabotage of diagnostic processes.  
— Additionally, increased security risks appear when ‘physical devices’ are involved, such as 
companion robots assisting persons with disabilities or the elderly, or surgical robotic systems. 
— Bias and fairness: Do AI systems have biases or are they fair with different (e.g. ethnic, gender, 
age) groups in diagnosis, prognosis and treatments? Do they receive proper, balanced data for 
training? Are results valid? 
— The social impact of ‘erroneous data for learning’ can be very high. System may not give any 
warning but processing results may be incorrect. 
— Empathy, including shared decisions and (‘the machines’) helping humans to make difficult 
decisions. 
— Citizen (taxpayer) opinion and involvement in a ‘patient-centric’ model. Questions include the 
common-good in public-funded research, informed consent, citizen science, the ‘reduced 
asymmetry’ in information between the patient and the doctor, and citizen-generated 
(genetic, ...) tests without a doctor prescribing them and analyzing their results. 
— Test, benchmarking. There is a clear need for updated testing and evaluation procedures. This 
is a key issue in which relevant changes are required. 
— Regulation, and the legal aspects related to liability and malfunction. There are no (updated, 
international) regulatory standard for most types of AI applications. Who is legally accountable 
if the system fails? The ‘original’ human designer? The programmer? The person who provided 
the training cases for the AI system to learn? The physician/human operator who used the 
system? The AI system itself? 
— Affordability and socio-economic impact. Global figures and market of AI in Medicine and 
Healthcare forecast very relevant, positive impact for the coming years. However, the 
economic analysis must include the social points related to health systems, the industries and 
the patients, as such technologies also risk evolving into a significant factor of inequality. 
— Information for the public and professionals about the real efficacy of AI-mediated treatments 
and clinical tools, especially against severe diseases of deep social interest –such as cancer– as 
compared to the many ‘announcements’ of ‘spectacular (initial) results’ which, are not later 
proven to be particularly useful in routine clinical use. 
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— The availability of trustworthy, open-access information –warranted by public services– is 
essential to reduce the risks of ‘fake-based’ medicine and to protect citizens from ‘digital 
health scammers’, 
— and, of course, as related to the issue of human-in-the-loop, the question of whether (or not) 
harnessing AI systems under human control on life and death decisions. Should we allow ‘a 
machine’ to take such decisions (on us, on a relative)?  
To this point, it should be considered that there is an ongoing (although partially silent) social debate 
–even at a 2019 Meeting in the United Nations– about the development of other types of machines 
with the ability to make decisions with regards to human life, the already mentioned lethal 
autonomous weapons systems (LAWS). Their objectives are clearly the opposite of medical devices, 
and the popular name of ‘killer robots’ prevent them from being included in medical literature, but the 
fundamental idea to discuss is the same: will ‘a machine’ take the ultimate decision to keep or end a 
human life? 
The Third Group (G3) includes certain aspects barely -or not included at all- in analysis of AI 
applications in Medicine and Healthcare, such as: 
— Humanization of care, allowing for more time with the patient that improves clinical outcomes 
and relieves high stress levels (burnout, suicide rates) of physicians. However, AI systems still 
lack the (much needed) ability of a physical (contact) examination of the patient. 
— Social engineering, profiling based on merged medical, health and social data. This issue 
questions the use of such merged information for the preventive detection of events of clinical 
significance (e.g. suicide) and for commercial uses (e.g. tailored marketing, insurance, health 
care coverage or employment). A significant topic is the potential genetic screening of (the 
whole, groups of) population (detailed below). 
— The availability of (unsupervised, unreliable) multiple data, genetic tests for anyone, with the 
risk of ‘patient-generated’ medicine (see 3.10). 
— Limits to data use? Post-mortem data inheritance? Should there be any limit to the use of very 
personal information (e.g. from Extended Personalized Medicine)? What happens when a 
person dies? Should personal data (e.g. genetic data) remain available for use by AI systems? 
Should there be a post-mortem limit? Can personal (medical, biological) data be inherited? By 
a relative or by a public institution? For commercial use? What happens if data are of high 
scientific value (e.g. belonging to a person with a rare disease)? Or with the potential of being 
directly used to treat a disease? 
— The expanding availability of crowd-sourcing of algorithms and processing power. The free 
sharing of expertise, know-how, and experience define a debate of ‘solidarity’ vs risks of 
malicious use. 
— Reading and decoding brain signals. The hope for the severely impaired may be turned into 
‘mind reading’ technologies challenging privacy at its basics. 
— Interactions with neural processes, which can be applied to help in neurological, mental 
diseases and, potentially, to interfere with free will. 
— Gene editing as an enabler for self-experimentation in humans, with the risk of unexpected 
results and the potential for change of the genetic heritage. 
— Gene editing ‘to design’ humans and human-animal embryos. With the (already documented) 
risk of unexpected results in newborns and the unknowns derived from the creation of new 
types of human-animal beings (‘chimera’). 
— The two sides of technology. With the (relatively) easy weaponization of many of the 
mentioned AI and AI-mediated technologies and the corresponding high risk of bioterrorism. 
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— Whole-brain computerized emulation and ‘head transplant’, challenging the quest for 
immortality and the very definition of life. 
— The search for artificial life forms (explicitly declared for military purposes), questioning the 
definitions of life (natural, artificial) and death. 
— The balance of benefits versus risks and pitfalls and the very fundamental question of whether 
there should be (or not) limits to research and development?  
Many AI systems and AI-mediated applications show an intrinsic ‘mix’ of positive, negative, and 
controversial aspects depending on their specific implementations, and that, according to published 
information, their readiness levels vary from commercially available to very early, conceptual designs.  
The scientific and ethical criteria for the analysis of AI applications in Medicine and Healthcare also 
need a thorough review and updating. Current approach to test medical products and drugs is based 
on randomized, controlled trials on large sets of cases in which statistically significant changes are 
evaluated. However, the new paradigm of Personalized Medicine tailors diagnosis and treatments of 
very specific features -on a genetic level- of each individual. Innovative procedures should be 
developed to allow for valid evaluation processes within affordable limits of time and costs, and many 
questions arise: 
— How can those treatments be rigorously tested? Which are the time and cost required to find 
‘enough cases’ to ‘generate scientific evidence’?  
— How should AI systems be benchmarked? Should they be compared to a (possibly error-prone) 
human doctor or ‘against’ another ‘machine’?  
— Should there always be the possibility of a human-in-the-loop with the ability to override the 
AI system? Even if the human makes more errors than machines (in certain tasks)?   
Bottom-line of this set of considerations is that regulations and legislation clearly lag the technology, 
and that both technical and ethical debates should take place. Common ethical guidelines for the 
evaluation of technologies mostly date from the pre-digital era. Nowadays, which should be the figures 
of merit to consider? How should they be updated? Which are the roles of the public and the policy 
makers? 
 
3.6 Urgent needs identified by the World Health Organization 
The social impact of AI systems in Medicine and Health is particularly broad and important. It 
encompasses consequences at all levels, from individual citizens (patients, professionals, caregivers) 
to groups, industry and to the whole society. 
However, although some social aspects of the impact of AI systems in Medicine and Health are being 
studied, many technologies and applications are simply advancing (almost) without any further 
consideration about their social and ethical aspects. 
Notably, many of the issues presented in this Report coincide with six of the thirteen urgent priorities 
recently defined by the World Health Organization (at the beginning of 2020) for the coming decade 
[21]. These coinciding priorities explicitly include: ‘Harnessing new technologies’, ‘Earning public trust’, 
‘Protecting people from dangerous products’, ‘Making health care fairer’, ‘Expanding access to 
medicines’, and ‘Preparing for epidemics’.  
Within the specific priority of ‘Harnessing new technologies’, the WHO defines the challenge as ‘New 
technologies are revolutionizing our ability to prevent, diagnose and treat many diseases. Genome 
editing, synthetic biology and digital health technologies such as artificial intelligence can solve many 
problems, but also raise new questions and challenges for monitoring and regulation. Without a 
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deeper understanding of their ethical and social implications, these new technologies, which include 
the capacity to create new organisms, could harm the people they are intended to help’. 
 
3.7 Changes for professionals 
In general, there are many publications and studies about the technical features of AI systems in 
Medicine and Health, their (increasing) performance figures and metrics, and comparisons to human 
users and operators. The incorporation of AI-based technologies into the medical practice will produce 
substantial changes in (all) areas of Medicine and Healthcare, from the medical, scientific and technical 
grounds to workflow, clinical pathways and management, and to the relationship with the patients 
and the health systems and providers.  
Certain medical specialties, particularly those related to image and data analysis and interpretation 
(e.g. Radiology, Pathology, Dermatology, and the different branches of Surgery, Forensics, 
Epidemiology, Public Health and others), will experience profound transformations (some of which 
have already started) due to the adoption of new tools with expanding capabilities and increasing 
autonomy. There are (professional) voices in the debate arguing that some specialties will even 
disappear and jobs will be lost. Other jobs (e.g. related to genetic counseling, medical data scientists 
and engineers) will arise. 
Initial (technical) results in certain areas of application (diagnosis, surgical robotics, precision medicine) 
are not as spectacular as predicted, some of them even really disappointing and contradictory to the 
previous public announcements. Nevertheless, technology is advancing, technical challenges are being 
addressed, and systems improved.  
3.8 Empowerment and the new role of patients 
Very significant changes are happening in the role of the individuals in relation to their Healthcare and, 
particularly, in the relationship between the patient and the doctor in Medicine. These changes can be 
seen as an evolution to new paradigms of ‘individual involvement’ in health care and of ‘patient 
empowerment’ in medicine, and this evolution is fostered by AI and AI-mediated technologies through 
three main aspects: 
— The availability of online information, evolving from disperse, unstructured descriptions of 
symptoms and medicaments to interactive platforms offering healthcare advice to diagnosis 
and even schemes for disease treatment, and of personal biometric and physiological data 
from sensors and IoT devices. 
— The easy connections to a multitude of individuals or groups of persons with similar interests, 
diseases or treatments, all across the globe, in any language. 
— The increasing access to the individual’s genetic data without the need of a physician ordering 
such analysis. Only a drop of saliva and prices on the order of a hundred euros are required to 
have your own genome (at least partially) analyzed and searched for alterations which are 
potentially related to diseases. 
The evolution of individual behavior in relation to Medicine and Health Care presents a novel array of 
many advantages, pitfalls and un-addressed concerns. The overall access to many types of data has an 
important effect in the relationship between the patient and the doctor, namely the reduction of the 
‘asymmetry in information’ between them and the evolution towards a ‘patient-centric’ model. This 
new situation started with the generalized availability of information on online platforms of the 
internet and it has evolved with AI technologies for data mining and advanced –easier- user 
interaction. Suddenly, patients could ask ‘the Google Doctor’ about anything, from symptoms to the 
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side effects of treatments to advices for healthy lifestyle and then visit the real physician’s office with 
a list of ‘informed’ questions, requests and even complaints. Anyone can even have a (digital) ‘personal 
medical coach’. In the following years, it has become evident that there is no ‘a priory’ guarantee of 
the quality –even of the certainty– of the information found on internet searches. Very valuable 
resources can be mixed with completely erroneous –even maliciously misleading– material and a 
certain level of knowledge is required to find and understand the information of real interest for any 
case. In addition, to evaluate the clinical situation of a patient and potential treatment options there 
is also a clear need of the ‘integrated analysis’, of the ‘global vision’ provided by a qualified, trained, 
real doctor. The evolution of technology has expanded AI systems, starting from ‘basic’ –but very 
effective– symptom checkers to increasingly autonomous ‘digital doctors’. 
 
3.9 ‘Extended Personalized Medicine’ 
The original goal of Personalized Medicine is to exploit very specific biological (genetic) features of 
individuals for tailored diagnosis and treatment. Decoding the genome of each patient represents a 
very significant change from the existing model of averaged analysis of populations to an extremely 
individualized approach, for treating disease –in a new paradigm defined as ‘Precision Medicine’– but 
also to promote wellness and healthy, personalized lifestyles.  
However, although not explicitly formulated in the literature, the underlying principle of Personalized 
Medicine can be further expanded. It can include other properties whose particular values or 
structures –even their spatial distribution and time evolution in the human body– may be significantly 
different for any single individual, in different clinical situations, at every moment of life and, possibly 
in strong relationship to each other.  
The additional features that form the new concept of ‘Extended Personalized Medicine’ may come 
from: 
— ‘Known sources’ from the ‘basic sciences’ of physics (e.g. bioelectromagnetic fields and signals, 
biomechanical magnitudes and properties, hydrodynamic parameters of the circulation of any 
fluid in the body, …), chemistry (concentrations of ions, molecules, …), and biology 
(metabolites, …).  
— ‘Not yet known’ origins. This concept refers to the potential characterization of brain 
processing schemes, connections and functions whose details still remain veiled for science. 
— Demographic data, extracted from conventional databases. 
— Social data, including those about societal structures (family, groups providing psychological, 
emotional support) and cultural and religious beliefs which may influence health-related 
issues, such as restrictions on types of food or sexual activity, provided by the user or mined 
from social networks. 
— ‘Lifestyle parameters’ (sleep hours, stress, physical activity, food ingestion, …) easily accessible 
through apps, wearables and the Internet of Things. 
— Values of environmental and physical geography conditions (weather, contamination, …) 
transmitted by multiple platforms.  
— Sensors evaluating mood through face and gesture recognition, changes in cardiac rhythms, 
perspiration and breathing patterns when receiving certain visual or auditory stimuli. They 
may be biometrics readers in smartphones, domotic environments, and wearables. 
— Data about psychological and emotional status, extracted indirectly from the individual activity 
on social networks. 
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The accumulation of personal, intimate information of ‘Extended Personalized Medicine’ presents very 
high risks regarding ownership, security and privacy. From a technical point of view, the combination 
of so many sources of information, even ‘only’ using those that are already available –namely genetic 
data (genomics, metabolomics, proteomics, …), results coming from ‘standard tests’ (e.g. imaging 
scans, analytics), clinical scores, and medical knowledge in publications and references– requires the 
use of advanced AI-mediated tools, both for merging, processing and analyzing multiple data layers –
extracting useful information– and to operate the devices of augmented and virtual reality for the 
(very much needed) interactive navigation, visualization and interpretation of the relevant 
information.   
 
3.10 The risk of the division into several types of Medicine 
AI-supported, even shared-decisions –with non-human systems– and patient involvement shape 
substantial changes in Medicine and Healthcare. However, a very dangerous division of Medicine in 
different subtypes may therefore take place. They are the following: 
— ‘Fake-based’ medicine. Based on (unfounded, unconfirmed) rumors and ‘fake news’, this type 
of ‘pseudo-medicine’ may present ‘ancient, natural knowledge’ as opposed to scientific, 
evidence-based medicine, considered to be under malicious control by corporations, 
academia, institutions and governments. Even rejecting technology, it may easily take benefit 
from the expanding ability of fake news in social networks and the multiplying power of online 
platforms and AI-mediated tools (including chatbots, interactive apps, communities of 
followers) for dissemination of wrongful information. This type of misinformation, such as in 
the case of ‘anti-vaccine groups’, is currently increasing, being used to discredit ‘conventional’ 
therapeutic approaches and to promote that patients abandon treatments and follow-up by 
physicians, with very serious potential consequences –even with the risk of death– both for 
the individuals affected and their surrounding environments. 
— ‘Patient-generated’ medicine. This type of ‘pseudo-medicine’ derives from the growing online 
availability of many (both correct and unsupervised, unreliable) sources of medical 
information, even on platforms and apps supposed to evaluate and interpret the results of 
(almost any) type of analysis, including imaging scans and genetic tests.  
Although a ‘better informed patient’ is a positive consequence of the availability of 
information, individual-ordered analysis and diagnosis lack the (fundamental) ‘global vision’ 
that the doctor can offer to the patient and the (crucial) trained skills required for proper 
understanding of the results of any tests and deciding subsequent steps.  
Any person, even medically illiterate, without any medical education or training, may have –
through AI-mediated tools– immediate, unlimited access to a trove of information that she/he 
may consider correct and related to her/his disease or health issue. Resulting decisions may 
then –very probably– bring inadequate, even damaging, consequences, without the potential 
help or support from any established medical institution. 
— ‘Scientifically tailored’ Medicine. This type of medical science is the one that evolves from 
current research into extended personalized/precision medicine. For the patients, the critical 
decision would probably be the selection of the human doctor –perhaps the AI-system– to 
lead the team of ‘conventional’ (clinical) and ‘new’ (e.g. genetic counselors, medical data 
scientists) professional profiles required to correctly integrate the multiple, extensive sources 
of information to establish the diagnosis and define the corresponding treatment and 
monitoring strategies. 
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3.11 ‘Digital health scammers’  
In addition to the beneficial sources of medical data, AI tools have allowed the emergence of new types 
of online platforms that target those looking for information about health issues on the web. They are 
relatively easy to find through automated, systematic searches of social networks using natural-
language analyzers. When identified, candid patients are offered clinical advice and treatment options, 
even pharmacological and surgical.  
Problems obviously arise when there is no guarantee about the qualification or reliability neither of 
the ‘products’ offered nor of the service provider, and it happens to be an updated, AI-mediated, digital 
version of –long existing– ‘health scammers’. AI systems can be trained with wrongful, malicious data 
and have an ‘appearance’ of trustworthiness. This is a situation of particular relevance –and potential 
damage– for more vulnerable persons, such as those with severe diseases and their relatives. 
Undesirable scammers taking unfair advantage of persons can be traced back to the origins of 
Medicine. But the extraordinary multiplying effects of the internet and AI tools can make them much 
more powerful and dangerous, especially for citizens without the required knowledge to make critical 
analysis of the information received.  
In the age of expanding information, important goals of public, regulatory institutions should be to 
protect citizens from falling into the aforementioned types of ‘pseudo-medicine’ (‘fake-based’ and 
‘patient-generated’) and being victims of ‘digital health scammers’, and to allow for the (very 
challenging) generalized access of the population to the ‘scientifically tailored’ Medicine. To achieve 
such objectives, the availability of fair, trustworthy, contrasted information open to public access is 
essential.  
 
3.12 Affordability and inequality  
Global figures and market of AI in Medicine and Healthcare forecast very relevant, positive economic 
impact for the coming years. However, this analysis must include the ethical and social points related 
to health systems, the industries and the patients.  
It is important to note that the cost of decoding a human genome is substantially low –in the order of 
a few hundred euros– but the prices of some of AI-mediated treatments, such as certain personalized 
drugs, may reach ‘impossible’ figures, even in the order of millions of euros per case. This steep step 
is due to the difficulties of individually tailoring drug molecules to the specific genome of an individual. 
New models of health coverage, insurance, and affordability may be needed as such clinically excellent 
technologies pose a clear risk of evolving into a significant increasing factor of inequality for most 
people. 
 
3.13 The fundamental role and risks of neuroscience  
The impact of AI is especially relevant in neuroscience (neurosurgery, neurology). This area is based on 
the combination of AI-mediated technologies with advances in photonics (merging of applied optics 
and electronics) and engineering, together with other clinical disciplines (pharmacology, psychology) 
and related sciences (biology and genetics, biochemistry).  
As detailed in Table 3, AI-mediated advances in neuroscience have paved the way for the design -and 
early development- of techniques and devices for some limit-defying applications. Among them, 
reading and decoding the complex signals of the brain and their applications (e.g. visualization of 
neural processes in living beings in real time) using both invasive brain (chip) implants and non-
invasive, remote devices. Recently disclosed advances include a robot capable of inserting tiny (tether) 
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electrodes inside individual nervous fibers and a monkey having being able to control a computer 
through a chip implanted in its brain.  
Moreover, there are ambitious projects whose goals include mapping every individual signal and 
neural connection in the brain, and significant advances in different types of neurostimulation, e.g. 
using electromagnetic signals and fields, light beams (optogenetics), ultrasound beams and other 
forms of energy to stimulate, activate or deactivate signals in certain areas of the brain.  
From a clinical point of view, the knowledge about reading and interaction with brain signals can be 
used to develop interfaces to the human neural system, the goal of which is the interactive control of 
innovative prostheses, offering great hope for many persons with severely disabling conditions.  
However, this knowledge also relates to very controversial paths in which difficult questions arise: if 
signals inside the brain can be read using and external device, may such technology evolve to the 
potential ability to ‘read the mind’? Also, if brain signals can be stimulated and (perhaps) de/activated 
(that is, controlled) may we be able to generate ‘interferences’? which, in term, might lead to 
undesired forms of manipulation (lack of free will) and human control. And if all individual connections 
of neurons were correctly identified and read, would it allow for whole brain emulation (simulation)? 
And for ‘uploading’ all the brain information into a computerized system? 
Although these type of applications may seem ‘fantasy’ –and, perhaps, some of them may never 
became feasible– it is important to note that there are ongoing, very strongly funded projects in closely 
related areas. They are oriented to the positive aspects of neuroscience, by the EU (The Human Brain 
Project) [22] and by the USA (The Brain Initiative) [23]. Their goals are, respectively, ‘to explore brain 
structure and functions in humans ... and other species’, and ‘to deepen understanding of the inner 
workings of the human mind and to improve how we treat, prevent, and cure disorders of the brain’. 
Very recently, military projects related to research in man-machine interfaces have also been 
disclosed, and public calls have been open for scientists in these areas. 
A particularly controversial topic related to neuroscience (neurosurgery) in relationship to AI 
technologies is that of ‘head transplant’. It does not refer to a ‘digital avatar’ but to the real, physical, 
operative connection of the head of a (human) being to a different human body. It has been 
experimented in several animal models (with relative degree of success), and in 2017 it came to 
headlines as it was announced to have been performed on human cadavers, and to be attempted with 
a living human head in 2019 in China, although up to the date of this Report, there is no further public 
news about. The proclaimed intention is to help patients with terminal illnesses, neurodegenerative 
diseases and severe damage or section of the spinal cord, but such procedure obviously calls for many 
ethical –even philosophical– questions.  
From a strictly scientific point of view, these applications present many challenges of extreme 
complexity, in which AI-mediated tools may play an essential role, from augmented reality devices for 
surgery training and simulation to exploring, identifying and connecting (every? most? certain?) 
individual signals pathways to and from the brain. 
 
3.14 Gene editing, weaponization and bioterrorism 
Some of the AI technologies related to Medicine and Health can be weaponized or employed in novel 
forms of bioterrorism and evil applications. An example of particular interest in relation to security and 
safety are the AI tools required to design and implement the editing of the human genome.  
As in many other areas of science and technology, the same tools can be used for beneficial or 
malignant purposes but it is important to note the extraordinary effects –currently, mostly unknown– 
that some of the AI-related technologies may potentially be linked to Medicine, Biology and Chemistry. 
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Some of the currently available AI-related tools (see Table 3) include the possibility of introducing 
changes in the human genetic charge and (very possibly) the design of biological agents to target 
specific individuals, groups or populations. Other areas of applications of AI-related tools disclosed 
very recently include such issues as the design of human-animal hybrid embryos and the search for 
artificial life forms. Besides the unknown risks –and the very controversial ethical questions– the 
danger of ‘perverted’ or malicious use or design of such developments requires a thorough analysis. 
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4 A ‘Visual Overview’ of Artificial Intelligence in Medicine and Healthcare. 
Figure 1. Classification of AI and AI-mediated technologies in Medicine and Healthcare according to 
their ethical and social impact. SW: software, AR: augmented reality, VR: virtual reality, IoT: internet 
of things. TAL: Technology Availability Level.   
Some specific terms in this Report.   
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Figure 2. Ethical and social aspects of AI and AI-mediated technologies in Medicine and Healthcare. 
They are sorted in three groups (G1, G2, and G3). Some key relevant issues, controversies, significant, 
and conflicting issues are outlined for each aspect. 
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5 A ‘Structured Overview’ of Artificial Intelligence in Medicine and Healthcare 
 
The following Table 3 shows a structured overview of the field of AI in Medicine and Healthcare and 
their applications. It encompasses the state of the art by the date of this Report, including technologies 
and their implementations, perspectives, conflicting views and potential pitfalls, and the 
corresponding list of references consulted for this Report. 
 
 
 
30 
Table 3. Structured overview of the field of AI in Medicine and Healthcare, their implementations and technological set-ups and the corresponding list of 
references consulted for this Report. 
 
Fields Subfields References 
1. Motivation.   [3] [13] [15] [24] [25] [26] [27] [28]  
1.1. The context: AI enters Medicine 
and Health Care.   
[29] [30] [31] [32] [33] [34] [35] [36] 
[37] [38] [39] [40] [41] [42] [43] [44] 
[45] 
 1.1.1. Expected impact. Many positive, beneficial ideas. Specific reasons.  [46] 
  1.1.1.1. Obviously, the leading causes of death. [47] [48] [49] [50] [51] [52] [53] 
  1.1.1.2.  Tackling very complex problems. [54] 
  1.1.1.3. Human (medical) errors. [55] [56] [57] [58] 
  1.1.1.4. Universal Health Coverage as part of the Sustainable Development Goals of the UN. 
[42] [59] [60] [61] [62] 
 
 1.1.2. Economy aspects of AI in different world regions. Particularities in Medicine and Healthcare.  
[12] [16] [17] [18] [63] [64] [65] [66] 
[67] [68] [69] [70] [71] 
 1.1.3 Geostrategy.  [72] [73] [74] [75] [76] [77] [78] 
2. State of the art, current 
perspectives, conflicting views and 
potential pitfalls. 
   
2.1. Computer-aided diagnosis and 
decision support.   [79] [80] [81] [82] [83] 
 2.1.1. The pioneers: Radiology and medical imaging.  [84] [85] [86] [87] [88] [89] 
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  2.1.1.1. Advanced image enhancement and analysis. New approaches from other areas. [90] [91] [92] [93] [94] [95] 
  2.1.1.2. Quantitative imaging: the definition of biomarkers. 
[96] [97] [98] 
 
 2.1.2. Extracting information from clinical documents. Structured and e-health reports.  
[99] [100] [101] [102] 
 
 2.1.3. Extracting useful (but hidden) information from standard images.  [103] 
 2.1.4. Big Data and the power of integration of multiple modalities of information.  
[104] [105] [106] [107] [108] [109] 
[110] [111] [112] [113] 
2.2. Updates in some clinical areas.   [114] 
 2.2.1. Cancer and oncology.  [99] [115] 
  2.2.1.1. Breast. [116] [117] 
  2.2.1.2. Lung. [118] [119] [120] [121] [122] [123] [124] [125] 
  2.2.1.3. Other types of cancer. [126] 
 2.2.2. Cardiovascular.  [127] [128] [129] [130] [131] 
 2.2.3. Liver diseases.  [132] [133] [134] 
 2.2.4. Ophthalmology.  [135] [136] [137] 
 2.2.5. Gastrointestinal.  [138] [139] 
 2.2.6. Dermatology.  [140] [141] 
 2.2.7. Anesthesiology.  [142] 
 2.2.8. From primary care to aging to rare diseases.  [143] [144] [145] [146] 
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 2.2.9. Pathology and analytics. Towards optical biopsy and digital, virtual autopsy (‘virtopsy’).  [147] [148] [149] [150] 
2.3. Of singular relevance: 
neuroscience. The powerful merging 
of AI with (neuro)photonics for 
neurosurgery and neurology. 
  [22] [23] [151]  
 2.3.1. Seeing the whole brain (of living animals) in real-time operation.  [152] 
 2.3.2. Neuromodulation and control of neural processes.   
  2.3.2.1. Cortical and deep brain stimulation. [153] [154] [155] [156] 
  2.3.2.2. Peripheral stimulation. [157] 
 2.3.3. Towards optical control of the brain.   
  2.3.3.1. Using inserted probes: optogenetics. [158] [159] [160] [161] 
  2.3.3.2. Non-invasively: using the eye as a window to the brain. [162] 
 2.3.4. Neurology.  [163] [164] [165] [166] 
2.4. The AI revolution in surgery.    
 2.4.1. Early adopters in neurosurgery. Neuronavigation. Intraoperative fluorescence.  [167] [168] [169] [170] 
 2.4.2. Image-guided surgery.  [171] [172] [173] [174] [175] 
 2.4.3. Augmented reality and mixed reality. Teleoperation.  [176] [177] 
 2.4.4. Personalized surgical planning.  [178] [179] [180] 
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 2.4.5. Robotic-assisted surgery. Towards fully autonomous robotic surgeons.  
[181] [182] [183] [184] [185] [186] 
[187] [188] 
2.5. Clinical management of patients.    
 2.5.1. Clinical surveillance and monitoring, and (preventive) treatment. Wearables, IoT.  [189]  
  2.5.1.1. At bedside. [190] 
  2.5.1.2. At emergency room and the intensive care unit. 
[191] [192] [193] [194] [195] [196] 
[197] [198] 
  2.5.1.3. At long-term hospitalization and isolation rooms. [199] 
  2.5.1.4. At home and nursing homes. [200] [201] [202] [203] [204] 
  2.5.1.5. Of healthy/autonomous/aging persons. [205] [206] [207] [208] [209] [210] [211] [212] [213] 
  2.5.1.6. Of population groups. [214] [215] [216] [217] 
2.6. Towards extended 
personalized/precision medicine.    
 2.6.1. The application of human genomics.  [218] [219] [220] [221] 
 2.6.2. Personalized medicine: diagnosis, prediction of the response, tailored treatments.  [222] [223] [224] [225] [226] 
 2.6.3. Genetic testing.   
  2.6.3.1. Questions about generalized genetic screening of the population. [227] 
  2.6.3.2. Direct-to-consumer tests. [228] [229] 
 2.6.4. In-silico modeling and testing. The ‘digital 
twin’.  [230] [231] 
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 2.6.5. Drug design.  [232] [233] [234] 
 2.6.6. ‘Extended Personalized Medicine’.   
  2.6.6.1. Demographic, social, cultural, religious data. [235] [236] [237] 
2.7. ‘Social’ management of patients 
(and of persons who need specific 
care). 
   
 2.7.1. Companion and social robots.  [238] [239] [240] [241] 
  2.7.1.1. For children. [242] [243] [244] 
  2.7.1.2. For the elderly. [245] 
 2.7.2. Healthcare and social networks. Mobile health (mHealth), chatbots.  [246] [247] [248] [249] [250] 
  2.7.2.1. Use of dialogue systems for diagnosis. [251] 
 2.7.3. The (always) abandoned?  [252] 
2.8. Public health. Epidemiology.   [253] [254]  
 2.8.1. Epidemiology.  [255] [256] [257] [258] [259] [260] [261] 
  2.8.1.1. The example of the COVID-19 pandemic disease. 
[20] [262] [263] [264] [265] [266] 
[267] [268] [269] [270] 
 2.8.2. Health systems. Organizational improvements. Prediction of outcomes.  [171] [271] [272] [273] 
 
2.8.3. Merging of medical and social data to predict 
individual events of clinical relevance. The risks of 
‘social engineering’. 
  
  2.8.3.1. An example of debate: Liberty vs life protection in suicide prevention. [274] [275] 
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  2.8.3.2. A conflicting proposal: the search for links between mental health and violence. [276] 
  2.8.3.3. Tailored marketing: following female cycles and sexual activity. [277] 
 2.8.4. AI tools to combat health-related fraud.  [278] [279] 
 2.8.5. Quality control.  [280] 
2.9. Mental health.   [281] [282] 
 2.9.1. Computer-assisted therapies.  [283] [284] 
 2.9.2. Workers exposed to disturbing contents.  [285] 
2.10. Interfaces to the human neural 
system and neuroprosthetics.    
 2.10.1. Brain-machine interfaces.  [286] [287] [288] [289] [290] [291] 
  2.10.1.1. Auditory implants and speech reconstruction. [292] 
  2.10.1.2. Retinal implants. [293] 
  2.10.1.3. Implants (chips) in the brain. [294] [295] [296] 
 2.10.2. Neuroprosthetics. ‘Cyborgs’.  [297] [298] [299] [300] 
 2.10.3. Exoskeletons.  [301] [302] [303] 
2.11. AI-based medicine in reduced-
resources environments.    
 2.11.1. A very high potential.  [304] [305] 
  2.11.1.1. A specific example: snakebites. [261] 
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 2.11.2. Reality versus utopia: about the use of internet in developing regions.  [304] [306] [307]  
2.12. AI tools for stem cell research on 
human-animal embryos: chimera 
become real. 
   
 2.12.1. 2019 – Authorization for research in Japan.  [308] 
 2.12.2. 2018 – Human-sheep embryo disclosed.  [309] 
 2.12.3. 2017 – Interspecies (human-pig) cell growing.  [310] [311] [312] 
2.13. Self-experimentation medicine 
and biohacking.   [313] [314] [315] 
 2.13.1. Gene-enhanced ‘superhumans’.  [316] [317] 
2.14. The quest for immortality. 
Towards ‘artificial life’?   [318] [319] 
 2.14.1. Merging human intelligence with AI.  [320] 
 2.14.2. Brain models. Whole brain emulation.  [321] [322] 
 2.14.3. ‘Head transplant’.  [323] [324] [325] 
 2.14.4. ‘Living machines’, ‘biological robots’ 
(‘biobots’).  [326] 
2.15. Some examples of available 
systems using advanced AI tools.    
 2.15.1. Online platforms for clinical advice.  [327] [328] [329] [330] [331] 
  2.15.1.1. Symptom assessment platforms (for patients). [332] [333] 
  2.15.1.2. Dashboards for clinicians (in the hospital). [334] [335] 
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  2.15.1.3. Apps for electronic health records. [336] [337] 
 2.15.2. Apps for diagnosis.  [338] [339] 
 2.15.3. Genetic tests. Direct-to-consumer tests.  [340] [341] [342] [343] [344] [345] [346] [347] [348] 
 2.15.4. Gene editing (to cure diseases).  [349] [350] [351] 
 2.15.5. Surgical robots.  [352] [353] [354] 
 2.15.6. Companion robots.  [355]  
 2.15.7. Digital pathology.  [356] 
3. Conflicting views and potential 
pitfalls.    
3.1 The general debate: AI for global 
good? What about Medicine? Ethics.   
[37] [62] [235] [305] [357] [358] 
[359] [360] [361] [362] [363] [364] 
[365] [366] [367] [368] [369] [370] 
[371] [372] [373] [374] [375] [376] 
[377] [378] [379] [380] [381] [382] 
[383] [384] [385] [386] [387] 
3.2 Does ‘the machine’ perform better 
than a human physician does? ‘AI-
enhanced’ doctors?. 
  [388] [389] 
 3.2.1. In diagnosis.  [390] [391] [392] [393] [394] [395] [396] [397] [398] [399] [400] 
 3.2.2 In surgery.  [401] [402] 
 3.2.3 There are (still) technical questions to be addressed.  [403] 
3.3 Public perception of AI-based 
Medicine.    
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 3.3.1 Debunking the hype (only in part): some (early) applications disappoint.  [404] [405] 
  3.3.1.1. Questions about the results of precision medicine. [406] [407] [408] [409] [410] [411] 
  3.3.1.2. Questions about the results of robotic surgery. [412] [413] 
 3.3.2 The patient empowered. Direct-to-consumer genetic tests.  [407] [414] [415] [416]  
 3.3.3 Undermining experts. The difficult issue of 
‘fake news.  [417] [418] 
 3.3.4 The risk of ‘fake-based’ medicine.  [419] [420] 
3.4. Some of the most known issues: 
data privacy, anonymity, security.   [421] [422] [423] 
 3.4.1 Un/authorized use of medical data.  [424] [425] 
 3.4.2 Re-identifying anonymous data.  [426] [427] [428] 
 3.4.3 Data ownership. Post-mortem use?  [235] [424] [429] 
3.5 Who is responsible? 
Accountability.    
 3.5.1. The case of double reading of electrocardiogram.  [430] [431] 
 3.5.2. The ‘pocket doctor’?  [432] 
3.6. Explainability and the reality of 
‘black box’ systems.   [78] [433] [434] [435] [436] [437] 
 3.6.1. Reproducibility.  [438] [439] 
3.7. Trust.    
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 3.7.1. Of the patients in ‘AI doctors’. Always a 
‘human-in-the loop’?  [440] [441] [442] [443] [444] [445] 
 3.7.2. Of the employer in human physicians. Quality control?   
  3.7.2.1. An example: Use of AI to oversee prescriptions of opioids. [446] 
 3.7.3 The patient involved. Shared decisions.  [447] 
  3.7.3.1 The risk of surveillance anxiety. [448] 
  3.7.3.2 The risk of ‘patient-generated’ medicine. [418] 
 3.7.4. Reliability. Vulnerabilities. Adversarial 
behavior. ‘Digital health scammers’.  [372] [449] [450]  
3.8. Empathy and the humanization of 
care.   [451] [452] [453] [454] [455] 
 3.8.1. Helping the patient to take difficult decisions?  [456] [457] 
 3.8.2. Predicting your life span?  [99] [458] 
3.9 Bias. Fairness.   [368] [459] [460] [461] [462] [463] [464] 
3.10. Professional transformations. 
The fear to unemployment.   [465] 
 3.10.1. Who will lose their jobs? The pioneers at risk?  [150] [466] 
 3.10.2. Adaptation. The (absolute) need of professional updating.  [467] [468] [469] 
 3.10.3. New jobs (e.g. genetic counselors).  [67] [407] [470] [471] [472] 
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3.11. The economic cost of new 
therapies.    
 3.11.1. Optimal treatments at ‘impossible’ prices?  [473] [474] [475] 
 3.11.2. The role of industry.  [476] [477] 
 3.11.3. New models for health insurance and coverage?  [473] 
3.12. Collaborative and crowd-
sourcing algorithms for clinical 
applications. 
  [478] 
 3.12.1. An example in radiation therapy.  [479] 
3.13. The risks of unexpected results.   [480] [481] [482] [483] [484] 
 3.13.1. A recent (2018) example: Engineering human genes with unknown effects.  [485] [486] 
 3.13.2. Social profiling based on medical data. (Un)Fairness.  
[144] [221] [487] [488] [489] [490] 
[491] 
3.14. The two sides of technology: 
weapons, bioterrorism.   [492] 
 3.14.1 Some (recently disclosed) areas of military applications.   
  3.14.1.1. Brain-machine interfaces. [303] [493] [494] [495] 
  3.14.1.2. The eyes and the optical access to the brain. [166] [496] [497] [498] [499] 
  3.14.1.3. The search for synthetic life forms. 
[500] [501] 
 
 3.14.2. Evil biohacking: genome editing and manipulation.  [502] 
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3.15. The growing debate in the press 
and social media about AI related to 
Health and Medicine. 
   
 3.15.1. About benefits and ethical questions that arise.  
[115] [503] [504] [505] [506] [507] 
[508] [509] [510] [511] [512] [513] 
[514] [515] [516] [517] [518] [519] 
[520] [521] [522] [523] 
 3.15.2. About sharing medical data.  [424] [524] 
 3.15.3. About wearables, IoT and online health services.  [212] [525] [526] [527] [528]  
 3.15.4. About merging of clinical and social data. Suicide prevention.  [424] [529] [530] [531] 
 3.15.5. About overseeing of prescriptions.  [532] 
 3.15.6. About optogenetics, neurophotonics and the key role of neuroscience.  [533] [534] [535] 
 3.15.7. About direct, non-invasive mind reading.  [536] [537] 
 3.15.8. About surgical robotics, (neuro)prosthetics and human-machine interfaces.  [300] [538] [539] [540] [541] [542] 
 3.15.9. About genetic tests, privacy and the use of genetic and other personal data.  [221] [543] [544] [545] 
 3.15.10. About gene edition.  [546] [547] [548] [549] [550] [551] 
 3.15.11. About human-animal embryos.  [552] 
 3.15.12. About head transplant.  [553] [554] 
 3.15.13. About setting (or no) limits to research.  [555] [556] [557] [558] 
 3.15.14. About the (relevant) environmental impact of AI.  [559] 
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 3.15.16. About the ‘dark side’ of AI in Medicine and Healthcare.  [560] 
 3.15.16. About the use of AI in developing countries.  [305] [561] [562]  
3.16. Regulatory difficulties.    
 3.16.1. What to evaluate? How to evaluate?  [8] [407] [563] [564] [565] [566] [567] [568] [569] 
 3.16.2. How to regulate?  [476] [570] [571] [572] [573] [574] [575] 
3.17. Some (initial) responses to 
questions.   [576] [577] 
 3.17.1. In general, and in other areas of AI and robotics.  [8] 
  3.17.1.1. The ‘Montréal Declaration for Responsible Development of Artificial Intelligence’ (2018). [578] 
  3.17.1.2. Giving voice to consumers in the USA. [579] 
  
3.17.1.3. The social debate about autonomous killer 
robots. The Meeting in the United Nations about 
LAWS (2019) and the International Pledge for a Ban 
(2018). 
[580] [581] [582] [583] [584] [585] 
[586] [587] [588] [589] [590] [591] 
[592] [593] 
  3.17.1.4. About advances of AI in ‘typically human’ skills. [594] 
  3.17.1.5. About the cooperation of humans with machines. [595] 
  3.17.1.6. Robot teaching humans. [596] 
  3.17.1.7. About the social impact of AR/VR technologies. [597] 
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  3.17.1.8. About (initially) bad results of AI in other areas of high social impact (police applications). [598] 
 3.17.2. In areas related to AI in Medicine and Health.  
[407] [434] [599] [600] [601] [602] 
[603] [604] [605] 
  
3.17.2.1. The 2020 Declaration about ‘Urgent health 
challenges for the next decade’ by the World Health 
Organization. 
[21] 
 3.17.3. At the European level.  [1] [2] [3] [4] [13] [25] [63] [366] [565] [605] 
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6 Policy challenges 
 
6.1 Informed citizens 
The new areas –and the ethical and social challenges– that AI presents in Medicine and Health are 
mainly unbeknownst to most European citizens, although such aspects have profound consequences 
in society and relate to the adoption and expansion of the technologies. 
As detailed in Table 3, a growing public debate in the press and social media has already started about 
certain issues, mainly related to the aforementioned (partially) disappointing initial results in some 
specific areas of AI-based diagnosis, and about trust with regards to the new systems and data privacy 
and security.  
There is also an increasing number of voices (including highly-qualified scientists, physicians and 
entrepreneurs) asking for ‘true information’ about the real, applicable results of AI-mediated 
Medicine, particularly in areas of great social interest such as the cure of cancer and other diseases, 
‘preventive’ regulations (especially of the most dangerous and controversial topics) before ‘it is too 
late’, and a clear orientation towards the development of ‘human-centric’ AI. Most of these concerns 
are explicitly included in the mentioned ‘urgent priorities for the next decade’ defined by the WHO at 
the beginning of 2020. 
Advances of AI in Medicine and Health are partially driven by research, development and innovation 
based on public funding in the European Union. By the date of this Report there are some recent 
documents issued by EU institutions about technical issues related to AI, its extraordinary potential, 
adoption path, and economic impact, and about the social and ethical impact of AI in general and in 
the industrial context. Moreover, there is a growing concern regarding the interest and need of a 
specific analysis of the social impact of AI in Medicine and Health in the scientific, medical, clinical and 
technological communities, and an increasing number of related meetings. 
However, at the European or international levels there are no references to coordinated overview or 
analysis of the social impact of AI in Medicine and Health. In addition, there are no specific regulations 
about (many) of the most conflicting issues mentioned in this Report. 
 
6.2 Key aspects to evaluate 
A thorough and global evaluation of the social impact of AI systems in Medicine and Health should 
include all topics described in the previous paragraphs –synthetized in Figure 1 and Figure 2– with 
particular attention to those aforementioned issues that pose extended challenges. Among them, and 
as detailed in the references listed in Table 3: 
— The risk of dividing Medicine into the presented sub-types (‘fake-based’, ‘patient-generated’ 
and ‘scientifically tailored’). 
— Some specific issues related to data privacy, security and safety. 
— The ethics of decision for (fully) autonomous doctors, robotic surgeons or patient-controlling 
systems (e.g. in intensive care units). 
— Trust (e.g. in the relationship with a robotic doctor and in the confidence in the diagnosis, 
prognosis and proposals for treatment). 
— Empathy (e.g. in companion robots for the sick or the elderly and in automated systems 
‘helping’ humans to make difficult decisions). 
— Automated systems making decisions with a direct effect on the life and death of humans.  
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There also appear completely new –disruptive– aspects, not currently being addressed, which may 
impact the following:  
— Individual free will, in relation to brain implants, neuroprosthetics and (external) manipulation 
and control of neural processes. 
— Individual freedom, in applications such as generalized genetic screening, social engineering 
using (merged) medical data, self-experimentation medicine and do-it-yourself gene editing. 
— Genetic heritage for the coming generations. 
— Fundamentals and definitions of life, death and their frontiers, including the search for human-
animal embryos, artificial life forms and immortality. 
The implementation of detailed analysis of the ethical and social effects of AI technologies on Medicine 
and Health requires a truly inter- and multi-disciplinary approach, combining the views from many 
areas:  
— Clinical medicine and surgery, the ‘bio-related’ disciplines (biology, pharmacology, genetics, 
psychology, …) and new combined areas (neurophotonics, genetic counseling). 
— Computer science, information and telecommunication technologies, natural sciences 
(physics, mathematics, chemistry), engineering, robotics.  
— Humanistic, cultural and societal disciplines (ethics, philosophy, anthropology, sociology, 
history). 
— Defense, security and safety. 
— Legal, regulatory and policymakers. 
In addition, a global perspective is also needed: what happens in developed areas (the West) is inter-
related to developing regions (the Global South) and to any other world regions, both through the 
internet and through the easy means of transporting persons, animals and merchandise. 
A possible approach to tackling some of the challenges related to new risks would be to identify key 
technological elements required for the most sensitive applications and then regulate and monitor the 
distribution, availability and access to such materials. This would be somewhat similar to current 
procedures implemented for substances such as explosives and their precursors and radioactive 
elements, and it would obviously require the corresponding regulatory updates. 
 
6.3 Towards a European leadership 
Europe can –and must– lead the on-going revolution provided by AI-related technologies in Medicine 
and Health. The European Union has the scientific and technological skills and resources and the –also 
very much-needed– philosophical, ethical, social and historical background required for the successful 
leadership of such a revolution. Nevertheless, other global actors (e.g. USA or China) are currently 
investing in AI and digital technologies, particularly in Medicine and Health. 
The European Commission set out an AI strategy in April 2018 addressing the socioeconomic aspects 
in parallel with an increase in investment in research, innovation and AI capacity across the EU. It 
agreed a coordinated plan with Member States to align strategies, and established a High-Level Expert 
Group on AI that published Ethical Guidelines for Trustworthy AI in April 2019 [3]. These guidelines are 
made of seven core requirements and contain an assessment list for practical use by companies.  
The Commission has considered healthcare as a high-risk sector in the ‘White Paper on Artificial 
Intelligence – A European approach to excellence and trust’ COM(2020)65 [4], given the profound 
consequences of the adoption and expansion of such technologies and the need for an ecosystem of 
trust on AI.  
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In this context, we foresee the need to advance on the research and development of practical solutions 
for trustworthy AI in Medicine and Healthcare in the following aspects: 
i) Strengthen research into the social impact of AI in Medicine and Health in the three inter-related 
sectors: individuals (patients, professionals), social groups and society as a whole, by means of 
dedicated funding.  
It is important to note that this type of research (of the very specific social and ethical aspects of AI in 
Medicine and Health) is different from –although it clearly complements– the many R&D&I activities 
that are currently being developed about the scientific, technical and clinical aspects of such AI 
technologies, and in the social and ethical issues that are common to other areas of AI in industrial 
applications (such as the privacy and security of data, trust and fairness, legal responsibility and 
others). 
ii) Coordination and implementation of ethical and social guidelines for R&D&I of AI in Medicine and 
Health among EU members, starting from the Ethical Guidelines, and analyzing and prioritizing  
— the application of beneficial medical advances provided by AI against the leading causes of 
death, disease and disability and, in particular, following the urgent priorities defined by the 
World Health Organization at the beginning of 2020,  
— the analysis and control of the most potentially dangerous topics (namely, those related to 
devices for mind-reading and interaction and control of brain processes as opposed to free 
will, merging of medical and other types of data for ‘social engineering’, uncontrolled human 
gene editing and introduction of malicious changes in genetic heritage, human-animal hybrids, 
bioterrorism and weaponizing technologies and others), and  
— the design and implementation of ‘fundamental rules’ in certain areas of research and 
technology, before reaching the ‘it is too late’ limits. 
iii) Information for European citizens, to allow for the general public to have an educated opinion 
about the benefits, risks and ethical and societal impact of the technological proposals based on AI in 
Medicine and Health which may be funded by European taxpayers.  
Particular efforts should be started –as soon as possible– to protect European citizens from the very 
serious health risks derived from falling into ‘fake-based’ and ‘patient-generated’ types of ‘pseudo-
medicine’ and ‘digital health scammers’, and to allow for the (highly challenging) generalized access of 
the population to the very positive results of ‘scientifically tailored’ Medicine. 
iv) Leveraging European talent. Innovative actions should be taken to promote, foster and retain talent 
–particularly young– related to AI within the EU. European academics and entrepreneurs have 
outstanding levels of values and commitment in the new challenges posed by the interdisciplinary 
fields –and the new professional roles– that emerge in AI related to Medicine and Healthcare. Effective 
initiatives should be designed to promote their development inside the EU territories, discouraging the 
migration of highly qualified actors –scientific, technological, start-ups– to other geographical areas, 
and attracting others to come.    
v) Regulation and legislative actions, to allow for the advances of science and technology in Medicine 
and Health within the established ethical boundaries and, if possible, in coordination with other world 
regions.  
In view of the current state of the art and perspectives in this field, the EU should define an R&D&I 
coordinated effort to analyze the social impact of AI-related systems and technologies in Medicine and 
Health carried out in EU institutions, and to define the principles, ethical and societal guidelines and 
potential boundaries of research, development and implementation of AI-related technologies in 
Medicine and Healthcare as soon as possible.  
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7 An unexpected example: the coronavirus pandemic and its extraordinary social impact 
In early 2020, during the review process of this Report, the world was unexpectedly shaken by the 
(SARS-CoV-2) coronavirus and the COVID-19 pandemic disease, and its deep, ongoing impact in all 
aspects of daily life, particularly in some countries of the European Union. Given the rapid capacity of 
the Joint Research Centre to react to this important challenge, a brief link of this study with the current 
health emergency has been incorporated in this Report (see also 2.3).  
SARS-CoV-2 is a barely known virus, with a very efficient mechanism of contagion, and there is no 
available vaccine or treatment yet. This pandemic is having consequences worldwide and in all sectors, 
with an expected extraordinary, negative impact on economy, and, deeply, in people’s daily lives. 
Contention measurements trying to reduce the propagation of disease include massive quarantine and 
time-extended population confinement in many countries. This assumes a definite slowdown of 
activities and nearly a complete stop in many areas. The European Union is being strongly affected, 
and some European countries suffer a very difficult situation.  
There is an ongoing explosion of coronavirus-related literature in all scientific fields, e.g. as illustrated 
by the COVID-19 Open Research Dataset Challenge (CORD-19) [262]. In this initiative, a coalition of 
leading research groups has prepared the COVID-19 Open Research Dataset. This is a continuously 
growing resource, with many tens of thousands of scholarly articles, mostly available in full text, about 
COVID-19, SARS-CoV-2, and related coronaviruses. 
AI-mediated technologies –and the extraordinary efforts of people everywhere– lay at the main core 
of the response to this overwhelming health crisis. Virtually, most aspects included in the contents of 
our Report have proven to be important factors in the fight against the COVID-19 disease spread, as 
outlined below, and there is a growing arsenal of AI-related literature addressing the current 
coronavirus pandemic. The present condition needs a critical profound study on such questions, from 
medical, scientific, and technological approaches to related social and ethical aspects.  
Figure 1 mentions the potential of big data collection and analysis for medical diagnosis, epidemiology 
prevention and monitoring of disease outbreaks, as it is happening in the current situation. Computer 
vision techniques are being used to support the diagnosis of coronavirus on chest scans, as well as 
machine learning techniques facilitate the development of vaccines and treatments, the forecasting of 
infection and spread rates, and the exploitation of online and social media data to monitor the spread 
and public perception of the disease [263] [264]. Robotics, telemedicine and virtual doctors are also 
being exploited to replace human-human interaction in contaminated environments, e.g. to avoid 
infections or to disinfect hospitals [265], and AI-mediated tools help fight against misinformation and 
fake news or ‘fake-based medicine’ as presented in 3.10 and 3.11 [266]. 
In addition, many other social aspects mentioned in Figure 2 also being considered. They include the 
balance between need of data, social monitoring and control and privacy [267] [268] [269] [270].  
Saving lives and fighting the disease are clear, common goals in an exceptional situation with an 
extended, emotional impact at all levels of society. Society demands more than ever solutions to fight 
the current pandemic and prevent or minimize future crises. However, fundamentals questions 
pointed out in this Report suddenly arise with intricate, contradictory views in the debate: ‘social 
distancing’, extensive testing and temporary confinement of population are proposed –and, in many 
countries, enforced– to avoid contagion and stop the propagation of the disease. But should citizen’s 
displacement be individually tracked and controlled? Should every person (not only actual patients) 
be ‘classified’ and ‘color-tagged’ in a green-yellow-red scale using big data analytics? Should health 
data be transmitted to law-enforcement agencies? What will happen with the enormous amounts of 
individual data collected? How will this emergency change the design and usage of AI tools in the future 
and the invention of novel AI applications to fight such pandemic diseases?  Should there be any limits?  
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The current situation illustrates the duality addressed in this Report between controversial and 
positive usages of AI technologies in Medicine and Healthcare, and it will for sure be the subject of 
many future research. 
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8 Conclusions  
This Report provides a detailed state of the art of the current and near-future applications of Artificial 
Intelligence in Medicine and Healthcare. From this literature review, the Report proposes a 
categorization of these application in terms of their potential benefits, risks, and availability level. In 
addition, it also presents the emerging social debate on some related topics, and analyses the ethical 
and social impact of these technologies and the way they may change human behavior, transforming 
the roles of doctors and patients.  
From this discussion, it is formulated a set of policy challenges that will need to be addressed in the 
next future and some recommendations towards a European leadership in this sector. 
As a future work, this Report should be converted into a dynamic state of the art to reflect the changes 
in the proposed applications of AI in Medicine and Healthcare, availability levels, ethical and social 
aspects, list of references and policy initiatives.  
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Appendix: Selected conferences in 2019 
This section reports the conferences held in 2019 directly related to –or with specific sections about– 
the ethical and social aspects of AI in Medicine and Healthcare.  
 
Event: 105th Scientific Assembly and Annual Meeting of Radiological Society of North America. 
Date: December 1st-6th, 2019. 
Location: Chicago, USA. 
https://www.rsna.org/annual-meeting  
 
Event: Personalized Medicine Coalition: 15th Annual Personalized Medicine Conference. 
Date: November 13-14th, 2019. 
Location: Boston USA. 
http://www.personalizedmedicineconference.org/ 
 
Event: Artificial Intelligence Conference. 
Date: October 14-17th, 2019. 
Location: London, UK. 
https://conferences.oreilly.com/artificial-intelligence/ai-eu 
 
Event: Future of Health. 
Date: October 2-3th, 2019. 
Location: New York, NY, USA. 
https://events.cbinsights.com/future-of-health/rpaffo 
 
Event: Frontier of AI-Assisted Care (FAC) Scientific Symposium. 
Date: September 18-19th, 2019. 
Location: Stanford, CA, USA.  
https://med.stanford.edu/frontierofaicare.html 
 
Event: Intelligent Health. 
Date: September 11-12th, 2019. 
Location: Basel, Switzerland. 
https://intelligenthealth.ai/ 
 
Event: Intelligence. Innovation. Imaging. The perfect vision of AI. 
Date: April 5-6th, 2019. 
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Location: Barcelona, Spain. 
https://www.maiesr.org/programme/ 
 
Event: Health Hackathon. 
Date: March 30th, 2019. 
Location: Valencia, Spain.  
https://www.eventbrite.com/e/school-of-ai-health-hackathon-2019-valencia-spain-tickets-
55932713251 
 
Event: European Congress of Radiology. 
Date: February 27th- March 3th, 2019. 
Location: Vienna, Austria. 
https://www.myesr.org/past-congresses/ecr-2019 
 
Event: Next Generation Public Health: AI and Big Data 
Date: February 8th, 2019 
Location: London, UK. 
https://www.fondationbotnar.org/panel-event-next-generation-public-health-ai-and-big-data/ 
 
Event: HUMAINT Winter school on AI: ethical, social, legal and economic impact. 
Date: February 4-8th, 2019. 
Location: Centre for Advanced Studies, Joint Research Centre, European Commission. Seville, Spain.  
https://ec.europa.eu/jrc/communities/en/event/humaint-winter-school-ai-ethical-social-legal-and-
economic-impact 
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